STEVEN M PAUL
CIK 1237564 · CSO and President of R&D · last filed 2026-06-10
STEVEN M PAUL is a CSO and President of R&D who has filed 102 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for RAPP, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$76.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $51.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$51.92M
8
102
-$76.46M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | 28,284 | $38.40 | $1.09M | $1.03M | 3 | 2026-06-10 |
| SPTX | Director | 863,031 | — | — | $0 | 1 | 2026-05-04 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | CSO and President of R&D | 0 | $329.83 | $0 | -$29.76M | 12 | 2024-03-18 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | 303,377 | $8.68 | $2.63M | -$37.05M | 29 | 2024-01-04 |
| ALNY | Director | 10,799 | $282.85 | $3.05M | -$8.47M | 16 | 2022-04-05 |
| VYGR | Chief Executive Officer | 872,351 | $3.50 | $3.05M | $140.7K | 7 | 2021-06-04 |
| SIGMA ALDRICH CORP (SIAL) Delisted | Director | 0 | — | — | $0 | 19 | 2015-11-19 |
| LLY | EVP, Science and Technology | 39,476 | $1133.00 | $44.73M | -$2.35M | 15 | 2010-02-03 |
Recent Filings
102 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2026-05-04 | SPTX | Mixed | +67,031 | $0 | EDGAR |
| 2025-09-15 | RAPP | Buy (P) | +41,666 | $1.03M | EDGAR |
| 2025-06-18 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2024-03-18 | Karuna Therapeutics, Inc. (KRTX) Delisted | Disp (D) | −150,963 | -$49.82M | EDGAR |
| 2024-03-04 | Karuna Therapeutics, Inc. (KRTX) Delisted | Mixed | +47,378 | $14.93M | EDGAR |
| 2024-02-26 | Karuna Therapeutics, Inc. (KRTX) Delisted | Exer (M) | +31,518 | $599.7K | EDGAR |
| 2024-02-12 | Karuna Therapeutics, Inc. (KRTX) Delisted | Tax (F) | −804 | -$255.0K | EDGAR |
| 2024-01-04 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |